Cong Liang

1.3k total citations · 3 hit papers
29 papers, 864 citations indexed

About

Cong Liang is a scholar working on Molecular Biology, Obstetrics and Gynecology and Epidemiology. According to data from OpenAlex, Cong Liang has authored 29 papers receiving a total of 864 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 10 papers in Obstetrics and Gynecology and 6 papers in Epidemiology. Recurrent topics in Cong Liang's work include Endometrial and Cervical Cancer Treatments (9 papers), RNA modifications and cancer (5 papers) and Cervical Cancer and HPV Research (4 papers). Cong Liang is often cited by papers focused on Endometrial and Cervical Cancer Treatments (9 papers), RNA modifications and cancer (5 papers) and Cervical Cancer and HPV Research (4 papers). Cong Liang collaborates with scholars based in China, Hong Kong and United States. Cong Liang's co-authors include Jun Yu, Weixin Liu, Jianning Zhai, Yasi Pan, Huarong Chen, Dan Huang, William Ka Kei Wu, Hongyan Gou, Wei Kang and Yanqiang Ding and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Cong Liang

25 papers receiving 860 citations

Hit Papers

Lactobacillus gallinarum modulates the gut microbiota and... 2021 2026 2022 2024 2021 2022 2023 50 100 150
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Lactobacillus gallinarum modulates the gut microbiota and produces anti-cancer metabolites to protect against colorectal tumourigenesis
    2021 190 citations Naoki Sugimura, Qing Li et al. Gut profile →
  2. METTL3 Inhibits Antitumor Immunity by Targeting m6A-BHLHE41-CXCL1/CXCR2 Axis to Promote Colorectal Cancer
    2022 181 citations Huarong Chen, Yasi Pan et al. Gastroenterology profile →
  3. Targeting m 6 A reader YTHDF1 augments antitumour immunity and boosts anti-PD-1 efficacy in colorectal cancer
    2023 154 citations Yi Bao, Jianning Zhai et al. Gut profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cong Liang China 12 598 221 176 97 70 29 864
Zhonghua Jiang China 19 551 0.9× 320 1.4× 86 0.5× 131 1.4× 118 1.7× 61 868
Shuo Zeng China 10 608 1.0× 274 1.2× 110 0.6× 61 0.6× 62 0.9× 13 797
Ran Yang China 14 676 1.1× 85 0.4× 108 0.6× 91 0.9× 63 0.9× 37 1.0k
Regina Golan‐Gerstl Israel 14 851 1.4× 416 1.9× 58 0.3× 99 1.0× 70 1.0× 20 1.2k
Chaoqin Shen China 16 945 1.6× 643 2.9× 164 0.9× 68 0.7× 86 1.2× 18 1.2k
Anoop Singh Chauhan India 14 667 1.1× 187 0.8× 140 0.8× 117 1.2× 108 1.5× 19 1.0k
Yue He China 14 444 0.7× 299 1.4× 43 0.2× 66 0.7× 27 0.4× 23 712
Chien‐Yu Lin Taiwan 15 466 0.8× 235 1.1× 84 0.5× 59 0.6× 123 1.8× 44 869
Haixiang Sun China 14 441 0.7× 251 1.1× 164 0.9× 114 1.2× 58 0.8× 24 705
Xiumei Zhou China 18 441 0.7× 107 0.5× 243 1.4× 98 1.0× 84 1.2× 85 789

Countries citing papers authored by Cong Liang

Since Specialization
Citations

This map shows the geographic impact of Cong Liang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cong Liang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cong Liang more than expected).

Fields of papers citing papers by Cong Liang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cong Liang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cong Liang. The network helps show where Cong Liang may publish in the future.

Co-authorship network of co-authors of Cong Liang

This figure shows the co-authorship network connecting the top 25 collaborators of Cong Liang. A scholar is included among the top collaborators of Cong Liang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cong Liang. Cong Liang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Heming, Huarong Chen, Weixin Liu, et al.. (2025). Targeting of the m6A eraser ALKBH5 suppresses stemness and chemoresistance of colorectal cancer. Nature Communications. 17(1). 803–803.
2.
3.
Liao, Xiaolin, et al.. (2024). Safety study on adverse events of zanubrutinib based on WHO-VigiAccess and FAERS databases. Expert Opinion on Drug Safety. 25(1). 193–200. 2 indexed citations
4.
Liang, Cong, Yu Li, Wenyan Tang, et al.. (2024). MG132 inhibits proliferation and induces apoptosis of acute lymphoblastic leukemia via Akt/FOXO3a/Bim pathway. Human & Experimental Toxicology. 43. 3540321270–3540321270.
5.
6.
7.
Wang, Lu, Ping Liu, Hui Duan, et al.. (2023). Abdominal type B vs. type C radical hysterectomy in early-stage cervical cancer: A matched single center cohort report. Frontiers in Surgery. 10. 1166084–1166084.
8.
Bao, Yi, Jianning Zhai, Huarong Chen, et al.. (2023). Targeting m 6 A reader YTHDF1 augments antitumour immunity and boosts anti-PD-1 efficacy in colorectal cancer. Gut. 72(8). 1497–1509. 154 indexed citations breakdown →
9.
Liang, Cong, Haixia Jiang, Lixin Sun, et al.. (2023). Which factors predict parametrial involvement in stage IB cervical cancer? A Chinese multicentre study. European Journal of Surgical Oncology. 49(9). 106936–106936. 2 indexed citations
10.
Liang, Cong, Shan Kang, Weili Li, et al.. (2023). Risk factors for and delayed recognition of genitourinary fistula following radical hysterectomy for cervical cancer: a population-based analysis. Journal of Gynecologic Oncology. 34(2). e20–e20. 3 indexed citations
11.
Pan, Yasi, Huarong Chen, Xiang Zhang, et al.. (2023). METTL3 drives NAFLD-related hepatocellular carcinoma and is a therapeutic target for boosting immunotherapy. Cell Reports Medicine. 4(8). 101144–101144. 91 indexed citations
12.
Chen, Huarong, Yasi Pan, Qiming Zhou, et al.. (2022). METTL3 Inhibits Antitumor Immunity by Targeting m6A-BHLHE41-CXCL1/CXCR2 Axis to Promote Colorectal Cancer. Gastroenterology. 163(4). 891–907. 181 indexed citations breakdown →
13.
Li, Jinwei, et al.. (2022). Comprehensive Analysis of the Differential Expression and Prognostic Value of Histone Deacetylases in Glioma. Frontiers in Cell and Developmental Biology. 10. 840759–840759. 13 indexed citations
14.
Sugimura, Naoki, Qing Li, Eagle S.H. Chu, et al.. (2021). Lactobacillus gallinarum modulates the gut microbiota and produces anti-cancer metabolites to protect against colorectal tumourigenesis. Gut. 71(10). 2011–2021. 190 indexed citations breakdown →
15.
Li, Weili, Cong Liang, Ping Liu, et al.. (2021). Predictive value of microvessel features for the clinical response to neoadjuvant chemotherapy in cervical squamous carcinoma and the associations with prognosis. Translational Cancer Research. 10(1). 162–173. 4 indexed citations
16.
Wang, Lina, Cong Liang, Yu Li, et al.. (2020). Arsenic trioxide induces autophagic degradation of the FLT3-ITD mutated protein in FLT3-ITD acute myeloid leukemia cells. Journal of Cancer. 11(12). 3476–3482. 11 indexed citations
17.
18.
Liang, Cong, Ping Liu, Zhumei Cui, et al.. (2019). Effect of laparoscopic versus abdominal radical hysterectomy on major surgical complications in women with stage IA-IIB cervical cancer in China, 2004–2015. Gynecologic Oncology. 156(1). 115–123. 39 indexed citations
19.
Xu, Bing, Xiaowei Li, Jipeng Yin, et al.. (2015). Evaluation of 68Ga-Labeled MG7 Antibody: A Targeted Probe for PET/CT Imaging of Gastric Cancer. Scientific Reports. 5(1). 8626–8626. 19 indexed citations
20.
Li, Xiaosa, Jianyong Zheng, Jinfeng Zhou, et al.. (2013). The significance of LRPPRC overexpression in gastric cancer. Medical Oncology. 31(2). 818–818. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhonghua Jiang Breakdown of academic impact, for papers by Shuo Zeng Breakdown of academic impact, for papers by Ran Yang Breakdown of academic impact, for papers by Regina Golan‐Gerstl Breakdown of academic impact, for papers by Chaoqin Shen Breakdown of academic impact, for papers by Anoop Singh Chauhan Breakdown of academic impact, for papers by Yue He Breakdown of academic impact, for papers by Chien‐Yu Lin Breakdown of academic impact, for papers by Haixiang Sun Breakdown of academic impact, for papers by Xiumei Zhou
Rankless by CCL
2026